3 Buy-Rated Biotech Stocks Under $10 With Big Upside Potential
While they are more suited for aggressive accounts, these three biotech stocks trading under $10 that could provide investors with some solid upside potential.
While they are more suited for aggressive accounts, these three biotech stocks trading under $10 that could provide investors with some solid upside potential.
These three energy stocks traded under the $10 level, have consensus Buy recommendations and could provide investors with some solid upside potential.
Coca-Cola once more has shown its commitment to expanding the diversity of its offerings through bolt-on acquisitions. Investors must be asking themselves what’s next.
Here are three beverage stocks and two telecoms that recently saw their 50-day moving average cross above the 200-day average and could be considered contrarian plays.
The reaction from shareholders of Mexico-based to the new NAFTA deal was positive Monday morning, though not strongly so.
Judging by the most shorted stocks traded on the New York Stock Exchange between the July 31 and August 15 settlement dates, those sellers were more active than we have seen in a while.
Judging by the most shorted stocks traded on the Nasdaq between the July 31 and August 15 settlement dates, those sellers were focused on one favorite -- Caesars Entertainment.
Judging by the most shorted stocks traded on the Nasdaq between the July 31 and August 15 settlement dates, those sellers were focused on one favorite -- Caesars Entertainment.
Judging by the most shorted stocks traded on the New York Stock Exchange between the July 31 and August 15 settlement dates, those sellers were more active than we have seen in a while.
As global demand for alcoholic beverages rises, Wall Street analysts expect to see solid to strong earnings growth from the biggest brewers and distributors over the next few years.
The annual Federal Reserve symposium at Jackson Hole, Wyoming, starts on Friday, and Fed watchers are pulling out their binoculars. Fed Chair Jay Powell is set to speak in the aftermath of being publicly…
La Jolla Pharmaceutical and Sarepta Therapeutics are among seven biotech stocks that have seen some notable insider trading recently.
Media coverage of the retail sector often suggests that brick-and-mortar store operators are gasping their final breaths. Yet, analysts expect some of them to be around and going strong for at least the next…
Golden crosses, typically seen as a bullish sign, recently happened to shares of Tesla and others, while death crosses, a bearish sign, occurred at Schlumberger and others.
Judging by the most shorted stocks traded on the New York Stock Exchange between the July 13 and July 31 settlement dates, those sellers were focused on one favorite, Bank of America.
Judging by the most shorted stocks traded on the Nasdaq between the July 13 and July 31 settlement dates, those sellers were looking for direction, as moves in their favorites were mixed and modest.
The PepsiCo board of directors has named the company’s next chief executive officer. Should investors worry about a big course change for this global snack and beverage giant?
Short sellers may be keeping an eye on two of their favorite stocks in the days ahead, as Sirius XM and Advanced Micro Devices are in retreat from recent multiyear highs.
Judging by the most shorted stocks traded on the New York Stock Exchange between the June 29 and July 13 settlement dates, those sellers were cautious.
Judging by the most shorted stocks traded on the Nasdaq between the June 29 and July 13 settlement dates, those sellers were cautious, as their favorites saw shrinking or flat short interest.